PD-L1 (CD274) copy number gain, expression, and immune cell infiltration as candidate predictors for response to immune checkpoint inhibitors in soft-tissue sarcoma.
about
Clinical applications of PD-L1 bioassays for cancer immunotherapy.Increased infiltration of M2-macrophages, T-cells and PD-L1 expression in high grade leiomyosarcomas supports immunotherapeutic strategies.Analysis of the immune infiltrate in undifferentiated pleomorphic sarcoma of the extremity and trunk in response to radiotherapy: Rationale for combination neoadjuvant immune checkpoint inhibition and radiotherapy.Clinicopathological and prognostic significance of PD-L1 expression in sarcoma: A systematic review and meta-analysis.Drug response to PD-1/PD-L1 blockade: based on biomarkers
P2860
PD-L1 (CD274) copy number gain, expression, and immune cell infiltration as candidate predictors for response to immune checkpoint inhibitors in soft-tissue sarcoma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
PD-L1 (CD274) copy number gain ...... bitors in soft-tissue sarcoma.
@en
type
label
PD-L1 (CD274) copy number gain ...... bitors in soft-tissue sarcoma.
@en
prefLabel
PD-L1 (CD274) copy number gain ...... bitors in soft-tissue sarcoma.
@en
P2093
P2860
P50
P1433
P1476
PD-L1 (CD274) copy number gain ...... bitors in soft-tissue sarcoma.
@en
P2093
Albrecht Stenzinger
Amelie Lier
Carsten Denkert
Felix Lasitschka
Frederick Klauschen
Gunhild Mechtersheimer
Hanno Glimm
Jan Budczies
Korinna Jöhrens
Manfred Dietel
P2860
P304
P356
10.1080/2162402X.2017.1279777
P577
2017-01-27T00:00:00Z